Evidence map›Paper›PMID 31383001›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.

Jiaxin Fan, Yanru Fan, Xiao Wang, Lingfang Niu, Limei Duan, Jinxiao Yang, Luo Li, Yingying Gao, Xiaohou Wu, Chunli Luo

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1.American journal of cancer research · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jiaxin FanKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Yanru FanKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Xiao WangDepartment of Urology Surgery, Neijiang First People's Hospital, Neijiang, People's Republic of China.
Lingfang NiuKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Limei DuanKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Jinxiao YangKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Luo LiKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Yingying GaoKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China.
Xiaohou WuDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Chunli LuoKey Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, School of Laboratory Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Chongqing, 400016, People's Republic of China. 100960@cqmu.edu.cn.
Chongqing Medical University · CN

Funding

National Natural Science Foundation of China No.81802543
6 · The paper itself

Abstract

backgroundMetabolic rewiring is a common feature of many cancer types, including prostate cancer (PCa). Alterations in master genes lead to mitochondrial metabolic rewiring and provide an appealing target to inhibit cancer progression and improve survival. Phospholipase C (PLC)ε is a regulator of tumor generation and progression. However, its role in mitochondrial metabolism remains unclear.

methodsThe GEO, The Cancer Genome Atlas, and the GTEx databases were used to determine Twist1 mRNA levels in tumors and their non-tumor counterparts. Fifty-five PCa and 48 benign prostatic hypertrophy tissue samples were tested for the presence of PLCε and Twist1 immunohistochemically. An association between PLCε and Twist1 was determined by Pearson's correlation analysis. PLCε was knocked down with a lentiviral short hairpin RNA. Mitochondrial activity was assessed by measuring the oxygen consumption rate. Western blotting analyses were used to measure levels of PPARβ, Twist1, phosphorylated (p)-Twist1, p-MEK, p-ERK, p-P38, and p-c-Jun N-terminal kinase (JNK). Cells were treated with inhibitors of MEK, JNK, and P38 MAPK, and an agonist and inhibitor of peroxisome proliferator activated receptor (PPAR) β, to evaluate which signaling pathways were involved in PLCε-mediated Twist1 expression. The stability of Twist1 was determined after blocking protein synthesis with cycloheximide. Reporter assays utilized E-cadherin or N-cadherin luciferase reporters under depletion of PLCε or Twist1. Transwell assays assessed cell migration. Finally, a nude mouse tumor xenograft assay was conducted to verify the role of PLCε in tumor formation.

resultsOur findings revealed that the expression of PLCε was positively associated with Twist1 in clinical PCa samples. PLCε knockdown promoted mitochondrial oxidative metabolism in PCa cells. Mechanistically, PLCε increased phosphorylation of Twist1 and stabilized the Twist1 protein through MAPK signaling. The transcriptional activity of Twist1, and the Twist1-mediated epithelial-to-mesenchymal transition, cell migration, and transcription regulation, were suppressed by PLCε knockdown and by blocking PPARβ nuclear translocation. The tumor xenograft assay demonstrated that PLCε depletion diminished PCa cell tumorigenesis.

conclusionsThese findings reveal an undiscovered physiological role for PLCε in the suppression of mitochondrial oxidative metabolism that has significant implications for understanding PCa occurrence and migration.

Indexed as

Oxidative PhosphorylationAdultAgedAnimalsCell Line, TumorDisease Models, AnimalGene Expression Regulation, NeoplasticGenes, ReporterHumansImmunohistochemistryMaleMiceMiddle AgedMitochondriaModels, BiologicalNeoplasm GradingNuclear ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoinositide Phospholipase Cphospholipase C epsilonPPARGC1A protein, humanTWIST1 protein, humanTwist-Related Protein 1MAPKMigrationMitochondrial metabolicPLCεProstate cancerTwist1Ubiquitination

Identifiers

PMID31383001
PMCPMC6683382
OpenAlexW2964882262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.